Yiyuan Jiang - BioNeutra Global Chief Officer
| BGACF Stock | USD 0.07 0.00 0.00% |
Insider
Yiyuan Jiang is Chief Officer of BioNeutra Global
| Phone | 780 466 1481 |
| Web | https://www.bioneutra.ca |
BioNeutra Global Management Efficiency
The company has return on total asset (ROA) of (0.0573) % which means that it has lost $0.0573 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.5535) %, meaning that it generated substantial loss on money invested by shareholders. BioNeutra Global's management efficiency ratios could be used to measure how well BioNeutra Global manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Doug Martin | General Mills | N/A | |
| Jane Xu | The A2 Milk | N/A | |
| Rhona Shakespeare | Aryzta AG PK | 49 | |
| Mark Sherwin | The A2 Milk | N/A | |
| Mark Pallot | General Mills | 50 | |
| David Akers | The A2 Milk | N/A | |
| Marcus Opitz | Aryzta AG PK | 62 | |
| Martin Huber | Aryzta AG PK | 53 | |
| Marie Pillai | General Mills | N/A | |
| Amanda Hart | The A2 Milk | N/A | |
| Jaime Montemayor | General Mills | 60 | |
| R Clark | General Mills | 68 | |
| William Drury | Artisan Consumer Goods | 61 | |
| Keith Cooper | Aryzta AG PK | N/A | |
| Urs Jordi | Aryzta AG PK | 58 | |
| Ronan Minahan | Aryzta AG PK | N/A | |
| Edith Bailey | The A2 Milk | N/A | |
| Paul Gallagher | General Mills | 55 | |
| Jo Jenkins | General Mills | 62 | |
| Jano Cabrera | General Mills | 49 | |
| Brady Millerberg | Aryzta AG PK | N/A | |
Management Performance
| Return On Equity | -2.55 | |||
| Return On Asset | -0.0573 |
BioNeutra Global Leadership Team
Elected by the shareholders, the BioNeutra Global's board of directors comprises two types of representatives: BioNeutra Global inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioNeutra. The board's role is to monitor BioNeutra Global's management team and ensure that shareholders' interests are well served. BioNeutra Global's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioNeutra Global's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ross Montagano, Chief Officer | ||
| Sheri OBrien, VP Marketing | ||
| Monica Barclay, Co Sec | ||
| Vinti Goel, VP Affairs | ||
| Jianhua Zhu, CEO, Founder | ||
| Yiyuan Jiang, Chief Officer |
BioNeutra Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is BioNeutra Global a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -2.55 | |||
| Return On Asset | -0.0573 | |||
| Profit Margin | (0.16) % | |||
| Operating Margin | (0.14) % | |||
| Current Valuation | 5 M | |||
| Shares Outstanding | 46.45 M | |||
| Shares Owned By Insiders | 36.85 % | |||
| Price To Sales | 0.25 X | |||
| Revenue | 15.4 M | |||
| Gross Profit | 2.89 M |
Currently Active Assets on Macroaxis
Other Information on Investing in BioNeutra Pink Sheet
BioNeutra Global financial ratios help investors to determine whether BioNeutra Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioNeutra with respect to the benefits of owning BioNeutra Global security.